InsiderTrades.com logo
David Zaccardelli net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

David Zaccardelli Biography and Net Worth

CEO of Verona Pharma PLC American Depositary Share
From December 2018 until its acquisition by Swedish Orphan Biovitrum for up to $915 million in November 2019, Dr Zaccardelli served as President and CEO of Dova Pharmaceuticals, a US company developing therapeutics for rare diseases. Previously, he was Acting CEO of Cempra, from December 2016 until the company’s merger with Melinta Therapeutics in November 2017. From 2004 until 2016, Dr Zaccardelli served in several senior management roles at United Therapeutics Corporation, including Chief Operating Officer, Chief Manufacturing Officer and Executive Vice President, Pharmaceutical Development and Operations. Prior to United Therapeutics, he founded and led a start-up company focused on contract research positions and held a variety of clinical research positions at Burroughs Wellcome & Co, Glaxo Wellcome, and Bausch & Lomb Pharmaceutical. Dr Zaccardelli received a Pharm.D. from the University of Michigan.

What is David Zaccardelli's net worth?

The estimated net worth of David Zaccardelli is at least $1.43 billion as of August 1st, 2025. Dr. Zaccardelli owns 13,376,144 shares of Verona Pharma PLC American Depositary Share stock worth more than $1,430,043,555 as of December 5th. This net worth approximation does not reflect any other investments that Dr. Zaccardelli may own. Additionally, Dr. Zaccardelli receives an annual salary of $1,270,000.00 as CEO at Verona Pharma PLC American Depositary Share. Learn More about David Zaccardelli's net worth.

How old is David Zaccardelli?

Dr. Zaccardelli is currently 60 years old. There are 4 older executives and no younger executives at Verona Pharma PLC American Depositary Share. Learn More on David Zaccardelli's age.

What is David Zaccardelli's salary?

As the CEO of Verona Pharma PLC American Depositary Share, Dr. Zaccardelli earns $1,270,000.00 per year. Learn More on David Zaccardelli's salary.

How do I contact David Zaccardelli?

The corporate mailing address for Dr. Zaccardelli and other Verona Pharma PLC American Depositary Share executives is 3 MORE LONDON RIVERSIDE, LONDON X0, SE1 2RE. Verona Pharma PLC American Depositary Share can also be reached via phone at 011-44-0-2032834200 and via email at [email protected]. Learn More on David Zaccardelli's contact information.

Has David Zaccardelli been buying or selling shares of Verona Pharma PLC American Depositary Share?

David Zaccardelli has not been actively trading shares of Verona Pharma PLC American Depositary Share in the last ninety days. Most recently, David Zaccardelli sold 208,912 shares of the business's stock in a transaction on Friday, August 1st. The shares were sold at an average price of $13.14, for a transaction totalling $2,745,103.68. Following the completion of the sale, the chief executive officer now directly owns 13,376,144 shares of the company's stock, valued at $175,762,532.16. Learn More on David Zaccardelli's trading history.

Who are Verona Pharma PLC American Depositary Share's active insiders?

Verona Pharma PLC American Depositary Share's insider roster includes Christina Ackermann (Director), Michael Austwick (Director), James Brady (Director), Kenneth Cunningham (Director), Lisa Deschamps (Director), David Ebsworth (Director), Martin Edwards (Director), Patrick Finn (Insider), Andrew Fisher (General Counsel), Mark Hahn (CFO), Claire Poll (General Counsel), Kathleen Rickard (Insider), Mahendra Shah (Director), Vikas Sinha (Director), Anders Ullman (Director), and David Zaccardelli (CEO). Learn More on Verona Pharma PLC American Depositary Share's active insiders.

Are insiders buying or selling shares of Verona Pharma PLC American Depositary Share?

In the last year, insiders at the sold shares 30 times. They sold a total of 2,932,176 shares worth more than $29,558,114.16. The most recent insider tranaction occured on August, 1st when Director Kenneth Cunningham sold 10,808 shares worth more than $142,017.12. Insiders at Verona Pharma PLC American Depositary Share own 4.8% of the company. Learn More about insider trades at Verona Pharma PLC American Depositary Share.

Information on this page was last updated on 8/1/2025.

David Zaccardelli Insider Trading History at Verona Pharma PLC American Depositary Share

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/1/2025Sell208,912$13.14$2,745,103.6813,376,144View SEC Filing Icon  
6/11/2025Sell400,000$11.40$4,560,000.0013,190,168View SEC Filing Icon  
5/29/2025Sell208,696$9.33$1,947,133.6813,590,168View SEC Filing Icon  
5/28/2025Sell157,704$9.30$1,466,647.2013,798,864View SEC Filing Icon  
5/27/2025Sell33,600$9.53$320,208.0013,956,568View SEC Filing Icon  
4/29/2025Sell90,360$8.98$811,432.8014,377,176View SEC Filing Icon  
12/6/2024Sell162,800$5.01$815,628.0014,204,752View SEC Filing Icon  
12/4/2024Sell67,608$5.00$338,040.0015,007,816View SEC Filing Icon  
12/2/2024Sell3,200$5.00$16,000.0015,075,424View SEC Filing Icon  
11/29/2024Sell98,888$5.01$495,428.8815,078,624View SEC Filing Icon  
11/27/2024Sell23,240$5.00$116,200.0015,177,512View SEC Filing Icon  
11/11/2024Sell2,400$5.00$12,000.0015,202,352View SEC Filing Icon  
11/4/2024Sell94,144$4.39$413,292.1615,204,752View SEC Filing Icon  
11/1/2024Sell46,888$4.38$205,369.4415,298,896View SEC Filing Icon  
10/25/2024Sell4,800$4.38$21,024.0014,591,736View SEC Filing Icon  
10/23/2024Sell16$4.38$70.0814,736,536View SEC Filing Icon  
10/21/2024Sell110,456$4.38$483,797.2814,894,464View SEC Filing Icon  
10/18/2024Sell245,784$4.38$1,076,533.9215,004,920View SEC Filing Icon  
8/7/2023Sell8,616$2.47$21,281.5216,431,800View SEC Filing Icon  
8/4/2023Sell150,000$2.50$375,000.0016,440,416View SEC Filing Icon  
8/2/2023Sell73,704$2.59$190,893.3616,707,688View SEC Filing Icon  
5/1/2023Sell455,536$2.58$1,175,282.8816,887,336View SEC Filing Icon  
2/1/2023Sell432,928$2.56$1,108,295.6817,342,872View SEC Filing Icon  
12/20/2022Sell600,000$2.12$1,272,000.0017,775,800View SEC Filing Icon  
8/9/2022Sell600,000$1.75$1,050,000.0015,263,560View SEC Filing Icon  
8/1/2022Sell32,904$0.70$23,032.8015,863,560View SEC Filing Icon  
5/3/2022Sell32,904$0.50$16,452.0016,351,328View SEC Filing Icon  
2/3/2022Sell52,056$0.73$38,000.88View SEC Filing Icon  
11/2/2021Sell52,056$0.64$33,315.84View SEC Filing Icon  
8/3/2021Sell16,000$0.76$12,160.00View SEC Filing Icon  
3/1/2021Sell43,392$1.14$49,466.88View SEC Filing Icon  
See Full Table

David Zaccardelli Buying and Selling Activity at Verona Pharma PLC American Depositary Share

This chart shows David Zaccardelli's buying and selling at Verona Pharma PLC American Depositary Share by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Verona Pharma PLC American Depositary Share Company Overview

Verona Pharma PLC American Depositary Share logo
Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodilator and an anti-inflammatory agent in a single compound, which is in Phase 3 clinical trials for the treatment of chronic obstructive pulmonary disease, asthma, and cystic fibrosis. It is developing ensifentrine in three formulations, including nebulizer, dry powder inhaler, and pressurized metered-dose inhaler. The company was incorporated in 2005 and is headquartered in London, the United Kingdom.
Read More

Today's Range

Now: $106.91
Low: $106.91
High: $106.91

50 Day Range

MA: $106.65
Low: $105.91
High: $106.95

2 Week Range

Now: $106.91
Low: $31.09
High: $106.93

Volume

N/A

Average Volume

1,457,608 shs

Market Capitalization

$9.21 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.05